# Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers

> **NCT03315494** · PHASE1 · COMPLETED · sponsor: **Oscotec Inc.** · enrollment: 24 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** SKI-O-703 capsule
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT03315494
- **Lead sponsor:** Oscotec Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-22
- **Primary completion:** 2016-12-21
- **Final completion:** 2016-12-21
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03315494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03315494, "Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03315494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*